Articles Tagged: Genetic Testing Accuracy
March 11, 2026
Making Waves with MAVES
Discover how a BRCA2 variant reclassification, thanks in part to new MAVEs data and the Ambry Classifi® Program, unlocked potentially life-saving options for a 2x…
BRCA
Breast Cancer
Genetic Testing
Genetic Testing Accuracy
MAVES
February 28, 2025
From Odyssey to Answers: How Progeny Helps Improve Rare Disease Care
For Rare Disease Day, genetic counselor Liam Riddle explores genetic testing solutions.
Genetic Counselors
Genetic Testing Accuracy
Pediatrics
progeny
Whole Exome Sequencing
February 19, 2025
Three Benefits of Ordering Exome Testing as Trios
Several studies have shown that running an exome “trio” with both biological parents increases the diagnostic yield and decreases the rates of variants of uncertain…
Family History
Genetic Testing
Genetic Testing Accuracy
Whole Exome Sequencing
November 15, 2024
How the Ambry Patient for Life™ Program Minimizes the Need for Provider-Initiated Exome Reanalysis Requests
One of the unique benefits of exome testing is the ability to return to the data from the initial analysis and reevaluate it for new,…
Genetic Testing
Genetic Testing Accuracy
Multigene Panel Testing
Tag
VUS
Whole Exome Sequencing
October 31, 2024
Striking the Perfect Balance in Designing Hereditary Cancer Tests: The Ambry Approach
Ambry’s balanced approach to designing hereditary cancer tests ensures our panels remain relevant and impactful, helping clinicians manage hereditary cancer risk with confidence.
Genetic Testing
Genetic Testing Accuracy
Hereditary Cancer
Multigene Panel Testing
Variant of Unknown Significance
VUS
October 17, 2024
The Evolution of Hereditary Cancer Testing: Why Pan-Cancer Panels Are the Future of Genetic Risk Assessment
Pan-cancer panels offer more comprehensive diagnoses, personalized risk assessments, and targeted prevention and treatment strategies.
BRCA1 & 2
Genetic Testing
Genetic Testing Accuracy
Hereditary Cancer
Multigene Panel Testing
Ovarian Cancer
Variant of Unknown Significance
VUS